Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer

Recruiting now

Conditions studied: Thoracic Cancer

In brief

This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of study enrollment until two weeks after radiotherapy completion. Subjects will complete a short satisfaction survey at the end of the study period. Other information that is collected as part of routine care for this patient population will be extracted from subjects' medical records during the study period and afterwards.

Key facts

Study ID

NCT06342284

Run by

The New York Proton Center

People needed

40

Starts

2024-03-22

Expected to finish

2031-03-21

Last updated by the study team

2026-04-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Plan for fractionated (≥15 treatments) proton beam thoracic radiotherapy with curative intent for lung cancer
• Non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) histology is permitted.
• Concurrent chemotherapy is permitted but not required..
• Previous thoracic radiotherapy is allowed.
• Ability to complete study surveys in English or Spanish
• Age >/= 18
• Concurrent enrollment on other trials is permitted
• Patients who already use wearable devices and/or smartphones that monitor physical activity are eligible for this trial, provided they agree to utilize the devices provided by the study team during the study period
• All patients must sign study-specific informed consent prior to study entry

You may not qualify if…

• Ongoing treatment for another cancer that is expected to affect the toxicity profile of thoracic radiotherapy
• Pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception; this exclusion is necessary because the treatment involved in this study may be significantly teratogenic

Where it is running

• New York Proton Center — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.